[Effect of EGCG on the proliferation and invasion of human hepatoma HepG2 cells]

Wei Sheng Yan Jiu. 2013 May;42(3):460-5.
[Article in Chinese]

Abstract

Objective: To investigate the effect and mechanism of EGCG on the proliferation and invasion of human hepatioma HepG2 cell.

Methods: Hepatioma HepG2 cell was treated with EGCG at different concentrations. The effect of EGCG on HepG2 proliferation was examined by CCK-8. The apoptosis of HepG2 treated with EGCG was observed by fluorescence microscopy and FCM via Annexin V-FITC/PI staining. The invasion of HepG2 was detected by Transwell assay. The expression of MMP-2 and VEGF was analyzed by ELISA.

Results: HepG2 proliferation was inhibited after treated with EGCG. The IC25 of 24 h and 48 h was 58.19 and 54.19 mg/L. The IC50 of 24 h and 48 h was 133.90 and 78.97 mg/L. The apoptosis of HepG2 was induced significantly after treated with 60 and 135 mg/L EGCG, and the number of cells crossing Matrigel membrane was (28.33+/-7.66) and 0 (P<0.05), and the inhibitory rate of invasion was 69.47% and 100%. The expression of MMP-2 and VEGF decreased significantly.

Conclusion: EGCG suppressed the proliferation and invasion of HepG2 with the possible mechanism of inducing apoptosis and down-regulating the expression of MMP-2 and VEGF in HepG2.

Publication types

  • English Abstract
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects*
  • Catechin / analogs & derivatives*
  • Catechin / pharmacology
  • Cell Proliferation / drug effects*
  • Hep G2 Cells
  • Humans
  • Matrix Metalloproteinase 2 / metabolism
  • Neoplasm Invasiveness / prevention & control
  • Sincalide
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Antineoplastic Agents
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Catechin
  • epigallocatechin gallate
  • MMP2 protein, human
  • Matrix Metalloproteinase 2
  • Sincalide